Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Positron-emission tomography enhancer is not a standard molecular target but refers to methods, agents, or technologies that improve the quality and diagnostic utility of PET imaging. This includes advanced image reconstruction algorithms (e.g., AI-based denoising), improved radiotracers, and hardware improvements. The primary goal is to increase image clarity, reduce noise, improve lesion detectability, and enable lower radiotracer doses.
AI-based denoising and superresolution, improved radiotracer pharmacokinetics, hardware improvements for higher resolution
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Positron-emission Tomography Enhancer (PET Enhancer).